Homology-dependent DNA Upkeep Inhibitor
YU238259 is actually a distinctive inhibitor of homology-dependent DNA fix(HDR), but will not prevent non-homologous finish-signing up for (NHEJ), in portable-structured GFP reporter assays.
Related Products:Bucladesine salt seas sodium
Hsp90 Inhibitor
PF-04929113 Mesylate, a prodrug of SNX-2112, is certainly an orally lively Hsp90 inhibitor, by using a Kd of 41 nM, plus triggers Her-2 damage, by getting an IC50 of 37 nM.
Attached Goods: Resminostat hydrochloridel
Histone methyltransferase Inhibitor
A-196 is really a strong and distinct inhibitor of SUV420H1 and SUV420H2 with IC50 concepts of .025 and .144 μM, respectively in excess of 100-retract critical over other histone methyltransferases and non-epigenetic desired goals..
Related Products: Air-con-CoA Synthase Inhibitor1
Ephrin Receptor inhibitor
ALW-II-41-27 is actually a special Eph receptor tyrosine kinase inhibitor, ideal for malignancy cure.
Related Products: Pimodivir , MS049
Tyrosine Kinases inhibitor
Sitravatinib (MGCD516) is really a distinctive little molecule inhibitor targeted towards a variety of RTKs connected with traveling a vehicle sarcoma cellular expansion, like c-Package deal, PDGFRβ, PDGFRα, c-Satisfied, and Axl.
Hooked up Items: Miriplatin ,RAD140
Product Catalog
Ingredient Collection
45 types of ingredient libraries for top rated throughput verification and info verification.
Research Places
Proteases/Proteasome
Chromatin/Epigenetic
JAK/STAT signaling
Tyrosine Kinase/Adaptors
PI3K/Akt/mTOR Signaling
MAPK Signaling
Apotosis
Ubiquitination
Angiogenesis
Immunology/Inflammation
DNA Difficulties/DNA Maintenance
See Much more…
USATel: 857-239-0968 Fax: 857-239-8801
E mail: marketing and advertising@targetmol.com
Set: A single Boston Location, Suite 2600, Boston, MA 02108.
This meaning was sent to advertising and marketing@tsbiochem.com by sarah.shi@targetmol.com
A single Boston Place, Collection 2600, Boston, Massachusetts, 02108
Unsubscribe from all the mailings Unsubscribe | Take care of Signing up | Forward Email | Statement Mistreatment